loviride has been researched along with r 86183 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Corte, BL | 1 |
| Kang, X; Kollman, PA; Kuntz, ID; Wang, J | 1 |
| Giridhar, R; Prajapati, DG; Ramajayam, R; Yadav, MR | 1 |
2 review(s) available for loviride and r 86183
| Article | Year |
|---|---|
From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Benzodiazepines; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; Imidazoles; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors | 2005 |
The search for potent, small molecule NNRTIs: A review.
Topics: Acquired Immunodeficiency Syndrome; Allosteric Site; Anti-HIV Agents; Benzodiazepines; Benzophenones; Drug Resistance, Viral; Imidazoles; Pyridones; Pyrimidines; Reverse Transcriptase Inhibitors | 2009 |
1 other study(ies) available for loviride and r 86183
| Article | Year |
|---|---|
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.
Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics | 2005 |